Benefits of S53P4 bioactive glass in benign bone tumor surgery

Our guest today is Head of Pediatric Orthopedic department, Johanna Syvänen from Turku University Hospital. Johanna is a pediatric orthopedic surgeon with over 30 peer-reviewed scientific publications. Today she is here to discuss the recently published clinical paper: Allograft Versus Bioactive Glass (BG-S53P4) in Pediatric Benign Bone Lesions.